Oxford Sciences Innovation
143
17M
74
15.89
33
0.48
5
- Stages of investment
- Areas of investment
Summary
Oxford Sciences Innovation is the famous Corporate Investor, which was founded in 2015. The company was established in Europe in United Kingdom. The main department of described Corporate Investor is located in the Oxford.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Oxford Sciences Innovation, startups are often financed by Oxford University Innovation, IP Group Plc, Innovate UK. The meaningful sponsors for the fund in investment in the same round are IP Group Plc, Woodford Investment Management, Rt Capital Management. In the next rounds fund is usually obtained by Parkwalk Advisors, Oxford University Innovation, Innovate UK.
The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline YASA Motors, Genomics, Proxisense For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular fund investment industries, there are Life Science, Health Care.
When the investment is from Oxford Sciences Innovation the average startup value is 50-100 millions dollars. The fund is constantly included in 7-12 deals per year. The high activity for fund was in 2018. Deals in the range of 5 - 10 millions dollars are the general things for fund. Speaking about the real fund results, this Corporate Investor is 40 percentage points more often commits exit comparing to other organizations.
Investments analytics
Analytics
- Total investments
- 143
- Lead investments
- 33
- Exits
- 5
- Rounds per year
- 15.89
- Follow on index
- 0.48
- Investments by industry
- Biotechnology (49)
- Health Care (46)
- Medical (28)
- Life Science (20)
- Therapeutics (19) Show 83 more
- Investments by region
-
- United Kingdom (135)
- United States (3)
- Netherlands (1)
- Finland (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 0.79
- Avg. company exit year
- 4
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Amber Therapeutics | 10 Jun 2024 | Biotechnology, Therapeutics | Early Stage Venture | 109M | England, London, United Kingdom |
| Sitryx Therapeutics | 27 Sep 2023 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 39M | England, Oxford, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.